Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Background Dietary polyphenol treatment of non-alcoholic fatty liver disease (NAFLD) is a
novel direction, and the existing clinical studies have little effective evidence for its …

NAFLD is the most common chronic liver disease worldwide, occurring in both obese and
lean patients. It can lead to life-threatening liver diseases and nonhepatic complications …

Nonalcoholic fatty liver disease is now recognized as the most common cause of chronic
liver disease with an increasing prevalence in both adults and children. Although the …

The gut is a selective barrier that not only allows the translocation of nutrients from food, but
also microbe-derived metabolites to the systemic circulation that flows through the liver …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, whose
etiology is poorly understood. Accumulating evidence indicates that gut microbiota plays an …

Background Epidemiological evidence has shown an association between coffee
consumption and reduced risk for chronic liver diseases, including metabolic-dysfunction …

Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common
complications of type 2 diabetes mellitus (T2DM). The pathogenesis of NAFLD involves …

Background Currently, there is no approved medication for non-alcoholic fatty liver disease
management. Pre-clinical and clinical studies showed that several bioactive molecules in …

Background As dietary approaches to stop hypertension (DASH) dietary pattern has been
shown to be effective in hypertension and obesity, the present study investigated the effects …